Zhejiang Cheng Yi Pharmaceutical Co Ltd
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co.,… Read more
Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.042x
Based on the latest financial reports, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a cash flow conversion efficiency ratio of 0.042x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥55.69 Million) by net assets (CN¥1.33 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Cheng Yi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Zhejiang Cheng Yi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Cheng Yi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Cheng Yi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Minerva S.A
SA:BEEF3
|
1.823x |
|
Haverty Furniture Companies Inc
NYSE:HVT-A
|
0.104x |
|
Linkage Software Co Ltd
SHG:688588
|
0.036x |
|
Anhui Huamao Textile Co Ltd
SHE:000850
|
0.115x |
|
Lion Travel Service Co Ltd
TW:2731
|
0.169x |
|
Cosmecca Korea Co. Ltd
KQ:241710
|
0.053x |
|
MayAir Technology (China) Co. Ltd. A
SHG:688376
|
N/A |
|
Ooma Inc
NYSE:OOMA
|
0.077x |
Annual Cash Flow Conversion Efficiency for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.27 Billion | CN¥205.72 Million | 0.163x | -0.10% |
| 2023-12-31 | CN¥1.20 Billion | CN¥194.78 Million | 0.163x | +7.02% |
| 2022-12-31 | CN¥1.09 Billion | CN¥165.94 Million | 0.152x | +5.89% |
| 2021-12-31 | CN¥998.88 Million | CN¥143.49 Million | 0.144x | -28.41% |
| 2020-12-31 | CN¥886.09 Million | CN¥177.81 Million | 0.201x | -14.76% |
| 2019-12-31 | CN¥768.96 Million | CN¥181.01 Million | 0.235x | +18.06% |
| 2018-12-31 | CN¥673.54 Million | CN¥134.30 Million | 0.199x | +79.10% |
| 2017-12-31 | CN¥599.57 Million | CN¥66.75 Million | 0.111x | -67.19% |
| 2016-12-31 | CN¥280.17 Million | CN¥95.08 Million | 0.339x | +7.65% |
| 2015-12-31 | CN¥259.92 Million | CN¥81.94 Million | 0.315x | -7.44% |
| 2014-12-31 | CN¥246.95 Million | CN¥84.11 Million | 0.341x | +42.35% |
| 2013-12-31 | CN¥201.40 Million | CN¥48.19 Million | 0.239x | +12.28% |
| 2012-12-31 | CN¥178.13 Million | CN¥37.96 Million | 0.213x | +117.73% |
| 2011-12-31 | CN¥102.60 Million | CN¥10.04 Million | 0.098x | -- |